These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32623077)

  • 21. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
    Bone Marrow Transplant; 2022 Jul; 57(7):1150-1163. PubMed ID: 35523848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Hicheri Y; Einsele H; Martino R; Cesaro S; Ljungman P; Cordonnier C
    Transpl Infect Dis; 2013 Jun; 15(3):251-8. PubMed ID: 23465046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey.
    Yeshurun M; Rozovski U; Shargian L; Pasvolsky O; van der Werf S; Tridello G; Knelange N; Mikulska M; Styczynski J; Averbuch D; de la Camara R
    Bone Marrow Transplant; 2023 Apr; 58(4):414-423. PubMed ID: 36653669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
    Bar M; Ott SM; Lewiecki EM; Sarafoglou K; Wu JY; Thompson MJ; Vaux JJ; Dean DR; Saag KG; Hashmi SK; Inamoto Y; Dholaria BR; Kharfan-Dabaja MA; Nagler A; Rodriguez C; Hamilton BK; Shah N; Flowers MED; Savani BN; Carpenter PA
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1784-1802. PubMed ID: 32653624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of nurses to protective environment in haematopoietic cell transplant setting: an international survey by the European Society for Blood and Marrow Transplantation.
    Agreiter I; Kozijn AE; Bakunina K; Averbuch D; Stringer J; Hutt D; Mikulska M; Bögel TN; Canesi M; Cloutman-Green E; Bosman PV; Gil L; Liptrott SJ; Murray J; Styczynski J;
    Bone Marrow Transplant; 2021 Jun; 56(6):1433-1440. PubMed ID: 33514921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation.
    Lee CJ; Labopin M; Beelen D; Finke J; Blaise D; Ganser A; Itälä-Remes M; Chevallier P; Labussière-Wallet H; Maertens J; Yakoub-Agha I; Bourhis JH; Mailhol A; Mohty M; Savani BN; Nagler A
    Am J Hematol; 2019 Apr; 94(4):431-438. PubMed ID: 30597620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density in children with fanconi anemia after hematopoietic cell transplantation.
    Petryk A; Polgreen LE; Barnum JL; Zhang L; Hodges JS; Baker KS; Wagner JE; Steinberger J; MacMillan ML
    Biol Blood Marrow Transplant; 2015 May; 21(5):894-9. PubMed ID: 25591848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Inamoto Y; Valdés-Sanz N; Ogawa Y; Alves M; Berchicci L; Galvin J; Greinix H; Hale GA; Horn B; Kelly D; Liu H; Rowley S; Schoemans H; Shah A; Lupo Stanghellini MT; Agrawal V; Ahmed I; Ali A; Bhatt N; Byrne M; Chhabra S; DeFilipp Z; Fahnehjelm K; Farhadfar N; Horn E; Lee C; Nathan S; Penack O; Prasad P; Rotz S; Rovó A; Yared J; Pavletic S; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Petriček I
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):e46-e54. PubMed ID: 30481594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT).
    Tappenden P; Wang Y; Sharrack B; Burman J; Kazmi M; Saccardi R; Bermejo I; Harvey R; Badoglio M; Farge D; Snowden JA
    Bone Marrow Transplant; 2020 Jul; 55(7):1473-1475. PubMed ID: 31745252
    [No Abstract]   [Full Text] [Related]  

  • 31. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Passweg JR; Labopin M; Christopeit M; Cornelissen J; Pabst T; Socié G; Russel N; Yakoub-Agha I; Blaise D; Gedde-Dahl T; Labussière-Wallet H; Malladi R; Forcade E; Maury S; Polge E; Lanza F; Gorin NC; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):659-664. PubMed ID: 31759159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.
    Ciurea SO; Cao K; Fernandez-Vina M; Kongtim P; Malki MA; Fuchs E; Luznik L; Huang XJ; Ciceri F; Locatelli F; Aversa F; Castagna L; Bacigalupo A; Martelli M; Blaise D; Handgretinger R; Roy DC; O'Donnell P; Bashey A; Lazarus HM; Ballen K; Savani BN; Mohty M; Nagler A
    Bone Marrow Transplant; 2018 May; 53(5):521-534. PubMed ID: 29335625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study.
    Gandhi MK; Lekamwasam S; Inman I; Kaptoge S; Sizer L; Love S; Bearcroft PW; Milligan TP; Price CP; Marcus RE; Compston JE
    Br J Haematol; 2003 May; 121(3):462-8. PubMed ID: 12716369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
    Yao S; Smiley SL; West K; Lamonica D; Battiwalla M; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1130-7. PubMed ID: 20188201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in trabecular bone score and bone mineral density following allogeneic hematopoietic stem cell transplantation.
    Lim Y; Baek KH; Kim HJ; Lee S; Lee JW; Kang MI
    Bone; 2019 Jul; 124():40-46. PubMed ID: 30959188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
    McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
    Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased bone mineral density is common after autologous blood or marrow transplantation.
    Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
    Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation nursing: a practice variation study.
    Bevans M; Tierney DK; Bruch C; Burgunder M; Castro K; Ford R; Miller M; Rome S; Schmit-Pokorny K
    Oncol Nurs Forum; 2009 Nov; 36(6):E317-25. PubMed ID: 19887345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Alexander T; Greco R
    Bone Marrow Transplant; 2022 Jul; 57(7):1055-1062. PubMed ID: 35578014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.